Tobacco and Cardiovascular Health

[1]  J. Richter,et al.  Thromboangiitis obliterans (Buerger's disease). , 2014, VASA. Zeitschrift fur Gefasskrankheiten.

[2]  D. Bernhard,et al.  The biology behind the atherothrombotic effects of cigarette smoke , 2013, Nature Reviews Cardiology.

[3]  F. Gao,et al.  Cardiac-Specific Overexpression of Metallothionein Rescues against Cigarette Smoking Exposure-Induced Myocardial Contractile and Mitochondrial Damage , 2013, PloS one.

[4]  Jianping Jin,et al.  Novel Mechanism of Aortic Aneurysm Development in Mice Associated With Smoking and Leukocytes , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[5]  H. C. Chen,et al.  Reactive nitrogen oxide species-induced post-translational modifications in human hemoglobin and the association with cigarette smoking. , 2012, Analytical chemistry.

[6]  R. Camarini,et al.  Environmental Tobacco Smoke Induces Oxidative Stress in Distinct Brain Regions of Infant Mice , 2012, Journal of toxicology and environmental health. Part A.

[7]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[8]  A. Goette,et al.  Nicotine, cigarette smoking and cardiac arrhythmia: an overview , 2012, European journal of preventive cardiology.

[9]  W. Almahmeed,et al.  Tobacco modalities used and outcome in patients with acute coronary syndrome: an observational report , 2012, Postgraduate Medical Journal.

[10]  K. Deland,et al.  Translating the WHO Framework Convention on Tobacco Control (FCTC): can we use tobacco control as a model for other non-communicable disease control? , 2011, Public health.

[11]  J. Røislien,et al.  The "smoker's paradox" in patients with acute coronary syndrome: a systematic review , 2011, BMC medicine.

[12]  A. Hackshaw,et al.  Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls , 2011, Human reproduction update.

[13]  G. Almanzar,et al.  Heat shock protein 60 and immune inflammatory responses in atherosclerosis. , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[14]  Jun Ren,et al.  Cardiac-specific overexpression of metallothionein rescues nicotine-induced cardiac contractile dysfunction and interstitial fibrosis. , 2011, Toxicology letters.

[15]  X. Zhong,et al.  [Effect of interleukin-17-producing CD4+ T helper lymphocytes on cigarette smoke-induced lung inflammation and emphysema in mice]. , 2011, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[16]  D. Angiolillo,et al.  Clopidogrel-drug interactions. , 2011, Journal of the American College of Cardiology.

[17]  S. Lebrun,et al.  Cigarette smoke enhances abdominal aortic aneurysm formation in angiotensin II-treated apolipoprotein E-deficient mice. , 2010, Toxicology letters.

[18]  N. Benowitz,et al.  Impact of Smokeless Tobacco Products on Cardiovascular Disease: Implications for Policy, Prevention, and Treatment: A Policy Statement From the American Heart Association , 2010, Circulation.

[19]  M. Mayes,et al.  Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial , 2010, Annals of the rheumatic diseases.

[20]  Hideo Tanaka,et al.  Changes in Weight, cardiovascular risk factors and estimated risk of coronary heart disease following smoking cessation in Japanese male workers: HIPOP-OHP study. , 2010, Journal of atherosclerosis and thrombosis.

[21]  R. Małecki,et al.  Thromboangiitis obliterans in the 21st century--a new face of disease. , 2009, Atherosclerosis.

[22]  Claes Held,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.

[23]  Haw‐Wen Chen,et al.  Cigarette smoke extract induces expression of cell adhesion molecules in HUVEC via actin filament reorganization , 2009, Environmental and molecular mutagenesis.

[24]  J. Buring,et al.  A prospective study of cigarette smoking and risk of incident hypertension in women. , 2007, Journal of the American College of Cardiology.

[25]  I. Laher,et al.  Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms. , 2007, Current vascular pharmacology.

[26]  Shah Ebrahim,et al.  Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) , 2007 .

[27]  Shah Ebrahim,et al.  Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) , 2007 .

[28]  Inder Singh,et al.  High-density lipoprotein as a therapeutic target: a systematic review. , 2007, JAMA.

[29]  Paula Jerrard-Dunne,et al.  Impact of Smoking and Smoking Cessation on Arterial Stiffness and Aortic Wave Reflection in Hypertension , 2007, Hypertension.

[30]  A. Denktas,et al.  Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial). , 2006, The American journal of cardiology.

[31]  P. Arkkila.  Orphanet Journal of Rare Diseases BioMed Central Review Thromboangiitis obliterans (Buerger's disease) , 2006 .

[32]  Rodney A. White,et al.  ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Ang , 2006, Journal of the American College of Cardiology.

[33]  Rodney A. White,et al.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography , 2006, Circulation.

[34]  J. Pope,et al.  Scleroderma treatment differs between experts and general rheumatologists. , 2006, Arthritis and rheumatism.

[35]  S. Al-Safi,et al.  Does Smoking Affect Blood Pressure and Heart Rate? , 2005, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[36]  Michael J. Thun,et al.  Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States) , 2005, Cancer Causes & Control.

[37]  N. Benowitz,et al.  Cigarette smoking and infection. , 2004, Archives of internal medicine.

[38]  Aldons J Lusis,et al.  Thematic review series: The Pathogenesis of Atherosclerosis Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.R400001-JLR200 The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL , 2004, Journal of Lipid Research.

[39]  J. Ambrose,et al.  The pathophysiology of cigarette smoking and cardiovascular disease: an update. , 2004, Journal of the American College of Cardiology.

[40]  A. Fernández-Cruz,et al.  Smoking cessation and weight gain , 2004, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[41]  S. Mohiuddin,et al.  Comparison of conservative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery. , 2004, Chest.

[42]  Shah Ebrahim,et al.  JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda , 2016 .

[43]  T. Fukui,et al.  The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis. , 2003, Preventive medicine.

[44]  D. C. Brewster,et al.  Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. , 2003, Journal of vascular surgery.

[45]  R. Samson,et al.  Acute Cardiac Effects of Nicotine in Healthy Young Adults , 2002, Echocardiography.

[46]  J. Egan,et al.  Comparison of echocardiographic markers of right ventricular function in determining prognosis in chronic pulmonary disease. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[47]  J. Manson,et al.  Relation between markers of systemic vascular inflammation and smoking in women. , 2002, The American journal of cardiology.

[48]  J. Marrugat,et al.  Age at onset of smoking is an independent risk factor in peripheral artery disease development. , 2002, Journal of vascular surgery.

[49]  H. Schuller,et al.  Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas. , 2001, Carcinogenesis.

[50]  S. Shapiro,et al.  Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. , 2000, The Journal of clinical investigation.

[51]  D. Cook,et al.  Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. , 2000, Archives of internal medicine.

[52]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[53]  D. Webb,et al.  Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. , 1999, Circulation.

[54]  A. Timmis,et al.  Clinical characteristics determining the mode of presentation in patients with acute coronary syndromes. , 1998, Journal of the American College of Cardiology.

[55]  S. Adnot.  [Tobacco: an atherogenic, thrombogenic or spasmogenic factor?]. , 1998, Archives des maladies du coeur et des vaisseaux.

[56]  J. Ji,et al.  Nitric oxide selectively inhibits intracellular Ca++ release elicited by inositol trisphosphate but not caffeine in rat vascular smooth muscle. , 1998, The Journal of pharmacology and experimental therapeutics.

[57]  L. Kuller,et al.  Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[58]  S. Coppack,et al.  Endothelial Dysfunction: Cause of the Insulin Resistance Syndrome , 1997, Diabetes.

[59]  S. Glantz,et al.  Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. , 1997, Circulation.

[60]  D. Adams,et al.  Chemokines: leucocyte recruitment and activation cytokines , 1997, The Lancet.

[61]  J. Ricotta,et al.  Nicotine and cotinine stimulate secretion of basic fibroblast growth factor and affect expression of matrix metalloproteinases in cultured human smooth muscle cells. , 1996, Journal of vascular surgery.

[62]  B R Davis,et al.  Coronary heart disease risk factors in men and women aged 60 years and older: findings from the Systolic Hypertension in the Elderly Program. , 1996, Circulation.

[63]  E. Forsberg,et al.  Catecholamine secretion induced by nicotine is due to Ca++ channel but not Na+ channel activation in porcine adrenal chromaffin cells. , 1996, The Journal of pharmacology and experimental therapeutics.

[64]  J. Collin,et al.  Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5‐year results of a randomized controlled study , 1996, The British journal of surgery.

[65]  R. Califf,et al.  Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded , 1995, Journal of the American College of Cardiology.

[66]  R. Wissler.  New insights into the pathogenesis of atherosclerosis as revealed by PDAY , 1994 .

[67]  R W Alexander,et al.  Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. , 1994, Circulation research.

[68]  G. Parati,et al.  Persistent blood pressure increase induced by heavy smoking. , 1992, Journal of hypertension.

[69]  D. Sparrow,et al.  Changes in urinary catecholamine excretion after smoking cessation , 1991, Pharmacology, Biochemistry and Behavior.

[70]  R. Etzel,et al.  Passive smoking alters lipid profiles in adolescents. , 1991, Pediatrics.

[71]  J. Millán,et al.  [Tobacco and arterial pressure (II.). The acute effects on the angiotensin-converting enzyme]. , 1990, Anales de medicina interna.

[72]  W. Mack,et al.  The influence of diet on the appearance of new lesions in human coronary arteries. , 1990, JAMA.

[73]  S. Narumiya,et al.  Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[74]  T. Clarkson,et al.  Mechanisms of atherogenesis. , 1987, Circulation.

[75]  W. Laskey,et al.  Acute coronary vasoconstrictive effects of cigarette smoking in coronary heart disease. , 1984, The American journal of cardiology.

[76]  G. J. Crystal,et al.  Regional renal and splanchnic blood flows during nicotine infusion: effects of alpha and of combined alpha and beta adrenergic blockade. , 1982, The Journal of pharmacology and experimental therapeutics.

[77]  Megan E. Piper,et al.  Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. , 2011, American heart journal.

[78]  A. Malarcher,et al.  State-specific prevalence of cigarette smoking and smokeless tobacco use among adults --- United States, 2009. , 2010, MMWR. Morbidity and mortality weekly report.

[79]  Office on Smoking.  How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General , 2010 .

[80]  Yuan Xiao-ling,et al.  Effects of cigarette smoking on the function of metabolizing arachidonic acid and angiotensin I in the isolated perfused rat lungs , 2008, Journal of Tongji Medical University.

[81]  Nikki Gillum,et al.  Cardiovasc Toxicol , 2008 .

[82]  W. Howard.  High-Density Lipoprotein as a Therapeutic Target: A Systematic Review , 2008 .

[83]  J. Pope.  The diagnosis and treatment of Raynaud's phenomenon: a practical approach. , 2007, Drugs.

[84]  L. Tanoue,et al.  Annual Smoking-Attributable Mortality, Years of Potential Life Lost, and Productivity Losses—United States, 1997–2001 , 2007 .

[85]  Office on Smoking.  The Health Consequences of Smoking: A Report of the Surgeon General , 2004 .

[86]  W. Ahrens,et al.  Nitrated and oxidized plasma proteins in smokers and lung cancer patients. , 2001, Cancer research.

[87]  J. W. Olin.  Thromboangiitis obliterans. , 1994, Current opinion in rheumatology.

[88]  R. Wissler.  New insights into the pathogenesis of atherosclerosis as revealed by PDAY. Pathobiological Determinants of Atherosclerosis in Youth. , 1994, Atherosclerosis.

[89]  M. Jarvik,et al.  Cardiovascular effects of nicotine gum and cigarettes assessed by ECG and echocardiography. , 1985, NIDA research monograph.